drugset / Trial / NCT05341141

Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy

NCT05341141

RandomizedParallel-groupOpen-labelPrevention

Summary

This is a prospective, multi-center, randomized study designed to evaluate the clinical efficacy of cryotherapy combined with compression therapy in preventing albumin-paclitaxel induced peripheral neuropathy.

Timeline

Start
2022-06-10
Primary completion
2026-08
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Background Cyclophosphamide Other / unclassified 600 mg/m2 Intravenous
Background Epirubicin Small molecule 90 mg/m2 Intravenous
Background Epirubicin Small molecule 100 mg/m2 Intravenous
Background Paclitaxel Small molecule 260 mg/m2 Intravenous

Indications